INCOME STATEMENT (Quarterly GAAP In millions $) |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
Revenue From Contract With Customer Including Assessed Tax |
1.33 |
|
3.25 |
1.03 |
0.62 |
Product Sales |
- |
|
- |
- |
- |
Product Sales Revenue |
- |
|
- |
- |
- |
Other Revenue |
- |
|
- |
- |
- |
Other Revenue |
0.15 |
|
0.38 |
0.17 |
0.10 |
Total Revenue |
1.48 |
0.59 |
3.63 |
1.20 |
0.71 |
Cost of Revenue |
0.64 |
0.88 |
1.45 |
0.53 |
0.36 |
Gross
Profit |
0.84 |
-0.29 |
2.18 |
0.67 |
0.35 |
Selling, Administration, Marketing |
4.22 |
5.76 |
4.32 |
4.75 |
3.54 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
0.76 |
0.58 |
0.61 |
1.00 |
1.07 |
Goodwill, Impairment Loss |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
0.00 |
- |
- |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
5.62 |
7.22 |
6.38 |
6.28 |
4.97 |
Operating income/-loss
|
-4.14 |
-6.63 |
-2.75 |
-5.08 |
-4.26 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Investment Income, Interest |
-0.08 |
0.61 |
0.09 |
-0.09 |
-0.24 |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-4.18 |
-0.94 |
-0.06 |
0.02 |
0.00 |
Fair Value Adjustment Of Warrants |
- |
12.10 |
-0.12 |
- |
- |
Total costs & expenses |
1.36 |
18.99 |
6.41 |
6.21 |
4.74 |
Income /-loss before income taxes |
0.12 |
-18.40 |
-2.78 |
-5.01 |
-4.03 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
0.12 |
-18.40 |
-2.78 |
-5.01 |
-4.03 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
0.12 |
-18.40 |
-2.78 |
-5.01 |
-4.03 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
0.12 |
-18.40 |
-2.78 |
-5.01 |
-4.03 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
-0.19 |
-0.20 |
-0.19 |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-0.07 |
-18.60 |
-2.98 |
-5.01 |
-4.03 |
EBIT |
0.12 |
-18.40 |
-2.78 |
-5.01 |
-4.03 |
EBITD |
0.34 |
-18.25 |
-2.51 |
-4.80 |
-3.83 |
EBITDA |
0.34 |
-18.25 |
-2.51 |
-4.80 |
-3.83 |